Cambridge, MA, United States of America

Gregory V Kryukov

USPTO Granted Patents = 11 

Average Co-Inventor Count = 5.4

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Cambridge, MA (US) (2021 - 2022)
  • Lexington, MA (US) (2022 - 2024)
  • Newton, MA (US) (2024)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Gregory V Kryukov: Innovator in Immunotherapy

Introduction

Gregory V Kryukov, based in Cambridge, MA, is a prominent inventor in the field of immunotherapy, holding 11 patents that reflect his dedication to advancing medical technology. His work focuses on enhancing the efficacy of immune effector cells, paving the way for innovative treatments for cell proliferative disorders, including cancer.

Latest Patents

One of Kryukov's latest patents is centered around "Gene-regulating compositions and methods for improved immunotherapy." This patent presents novel methods and compositions aimed at modifying immune effector cells to improve therapeutic efficacy. The innovative approaches involve reducing the expression of endogenous target genes or modifying endogenous proteins to enhance the functionality of immune cells. Additionally, these immune effector cells can be further modified by introducing transgenes that provide antigen specificity, including exogenous T cell receptors (TCRs) and chimeric antigen receptors (CARs). The implications of this patent are substantial, as it outlines methods for treating cancer using these modified immune cells.

Career Highlights

Kryukov's contributions to immunotherapy and regenerative medicine are significant, marked by his role in Ksq Therapeutics, Inc., where he continues to innovate within the biopharmaceutical sector. His expertise in the field is underscored by the number of patents he holds, which emphasize his commitment to research and development.

Collaborations

At Ksq Therapeutics, Kryukov collaborates with esteemed colleagues, including Jason J Merkin and Michael R Schlabach. These partnerships not only enhance the innovative environment at Ksq Therapeutics but also contribute to the collective advancements in the field of immunotherapy through shared insights and research efforts.

Conclusion

In conclusion, Gregory V Kryukov stands out as a valuable inventor whose work is shaping the future of immunotherapy. The patents he holds exemplify his commitment to improving treatment methodologies and the therapeutic landscape for cancer and other cell proliferative disorders. Through his ongoing collaborations and innovative spirit, Kryukov continues to make significant contributions to the realm of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…